The mechanism of cyclin D1 deregulation in NPC has been attributed to the activity of the EBV oncogenic protein, LMP-1, which has been shown to upregulate cyclin D1 transcription through the NFκB pathway and also increase Cdk4 expression in vitro21–23. This evidence concerns the gene CDK4 and nasopharyngeal carcinoma.